An interesting note in a Huntley daily update caught my attention today.
The note went roughly as follows:-
Shares in Genentech jumped 24.8%. This was after an analysis of a Phase III trial showed the company's Avastin treatment plus chemotherapy extended the survival of patients with certain lung cancers. The advance added roughly $11 billion to the value of investors' holdings in the stock.
Genentech is a very big company, but an $11 billion jump in capitilisation is just breathtaking.
Poor old Solbec is sitting at roughly $22 million in capitalisation (excluding options), just simply no comparison.
I would love (just dreaming) to see Solbec rise by even 1% of the rise that Genentech (that would be a five fold jump in sp).
- Forums
- ASX - By Stock
- SBP
- genentech up $11 billion
SBP
solbec pharmaceuticals limited
genentech up $11 billion
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)